| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/17/2007 | US20070110776 In vitro methods for evaluating the in vivo effectivness of dosage forms of microparticulate or nanoparticulate active agent compositions |
| 05/17/2007 | US20070110775 Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same |
| 05/17/2007 | US20070110740 Composition and methods for tissue preservation |
| 05/17/2007 | US20070110731 Integument Cell Regeneration Formulation |
| 05/17/2007 | US20070110709 Water-soluble stabilized self-assembled polyelectrolytes |
| 05/17/2007 | US20070110706 Treatment of hyperphosphatemia using crosslinked small molecule amine polymers |
| 05/17/2007 | US20070110689 Oral anaesthetic gel |
| 05/17/2007 | US20070110679 Process for Determining the Particle Size Distribution of an Aerosol and Apparatus for Carrying out Such a Process |
| 05/17/2007 | US20070110678 Method for administration of tiotropium |
| 05/17/2007 | US20070110677 Delivery of drugs to mucosal surfaces |
| 05/17/2007 | US20070110676 Compositions useful for prevention and treatment of common cold and influenza-like symptoms |
| 05/17/2007 | US20070110674 Sono-active liposomes and lipid particles and use thereof as contrast agents and active-agent delivery systems |
| 05/17/2007 | US20070110668 Modulation of Immunity and Ceacam1 Activity |
| 05/17/2007 | US20070108405 Compositions and methods for delivery of biologically active agents |
| 05/16/2007 | EP1785422A1 Micronised crystalline tiotropium bromide |
| 05/16/2007 | EP1785421A1 Tropan compound |
| 05/16/2007 | EP1785156A1 Pharmaceutical compositions |
| 05/16/2007 | EP1785145A1 Transnasal composition having immediate action and high absorbability |
| 05/16/2007 | EP1785141A1 Stabilized lanthanum carbonate compositions |
| 05/16/2007 | EP1785135A1 New stabilized galenic formulations comprising lansoprazole and their preparation |
| 05/16/2007 | EP1785131A1 External preparation of s/o type |
| 05/16/2007 | EP1784238A2 Counter pressure device for ophthalmic drug delivery |
| 05/16/2007 | EP1784225A2 Biomimetic of evodia rutaecarpa fruit extract for amelioration of inflammation |
| 05/16/2007 | EP1784215A1 1,4 o-linked saccharose derivatives for stabilizing antibodies or antibody derivatives |
| 05/16/2007 | EP1784202A1 Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus |
| 05/16/2007 | EP1784192A2 Vaginal cream compositions, kits thereof and methods of using thereof |
| 05/16/2007 | EP1784177A2 Novel formulation for l-tryptophane comprising carbidopa/benserazide |
| 05/16/2007 | EP1784174A1 A pharmaceutical composition comprising gabapentin |
| 05/16/2007 | EP1784171A1 Topical otic compositions and methods of topical treatment or prevention of otic infections |
| 05/16/2007 | EP1784170A2 Atrium patch |
| 05/16/2007 | EP1784169A1 Polymeric adhesive matrix with salified carboxylic groups for transdermal use |
| 05/16/2007 | EP1784168A1 Method of use herbal compositions |
| 05/16/2007 | EP1784167A2 Multi-layer tablets and bioadhesive dosage forms |
| 05/16/2007 | EP1784166A2 Compositions comprising 5-amino-2-hydroxybenzoic acid and a reducing sugar |
| 05/16/2007 | EP1784165A1 Stable particle formulations of erythropoietin receptor agonists |
| 05/16/2007 | EP1784164A2 Methods for transmembrane treatment and prevention of otitis media |
| 05/16/2007 | EP1784163A1 Nano-emulsion, the use thereof, and preparation method thereof |
| 05/16/2007 | EP1784162A2 System and method for modifying a fluid for oral administration |
| 05/16/2007 | EP1784161A1 Controlled-release formulation comprising tamsulosin hydrochloride |
| 05/16/2007 | EP1784160A1 Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers |
| 05/16/2007 | EP1784150A1 Transdermal antiemesis delivery system, method and composition therefor |
| 05/16/2007 | EP1784142A2 Musculo-skeletal implant having a bioactive gradient |
| 05/16/2007 | EP1784122A2 Implantable sensor with biocompatible coating for controlling tissue growth |
| 05/16/2007 | EP1725219A4 Method and apparatus for automatically modifying delivery profile of drug delivry system |
| 05/16/2007 | EP1667790B1 Device and method for making particles |
| 05/16/2007 | EP1610766B1 Amoxicillin trihydrate |
| 05/16/2007 | EP1545230B1 Coated chewing gum |
| 05/16/2007 | EP1539201A4 Antipyrotic and method of manufacturing the same |
| 05/16/2007 | EP1536807A4 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 05/16/2007 | EP1455805B1 A process for obtaining a zinc oxide containing product for skin-healing, care and protection in children and adults |
| 05/16/2007 | EP1372700B1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 05/16/2007 | EP1263347B1 System for the controlled delivery of an active material to a dental site |
| 05/16/2007 | EP1169340B1 Lantibiotic |
| 05/16/2007 | DE202007002978U1 Wässrige, desinfizierende Gelzubereitung Aqueous disinfectant gel preparation |
| 05/16/2007 | CN1964749A Coating compositions for bioactive agents |
| 05/16/2007 | CN1964748A Coating compositions for bioactive agents |
| 05/16/2007 | CN1964746A Polymeric compositions for sustained release of volatile materials |
| 05/16/2007 | CN1964744A Delivery system for bioactive agents on the basis of a polymeric drug carrier comprising an amphiphilic block polymer and a polylacticacid derivative |
| 05/16/2007 | CN1964743A Stabilized compositions comprising a therapeutically active agent, citric acid or a conjugated base and chlorine dioxide |
| 05/16/2007 | CN1964739A Uses of anti-CTLA-4 antibodies |
| 05/16/2007 | CN1964730A Herbal compositions for prevention and treatment rheumatic and inflammatory diseases and method of preparing the same |
| 05/16/2007 | CN1964727A Agent for removing factor causing circulatory dysfunction |
| 05/16/2007 | CN1964704A Stable pharmaceutical composition comprising an acid labile drug |
| 05/16/2007 | CN1964703A Immediate release pharmaceutical tablets with height greater than width |
| 05/16/2007 | CN1964702A Methods and dosage forms for controlled delivery of alprazolam |
| 05/16/2007 | CN1964701A Directly compressible tricalcium phosphate |
| 05/16/2007 | CN1964700A Pharmaceutical compositions |
| 05/16/2007 | CN1964699A Dry-form composition for oral ingestion and gel-form composition for oral ingestion of type prepared at time of use |
| 05/16/2007 | CN1964698A Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons |
| 05/16/2007 | CN1964697A Methods to control termites |
| 05/16/2007 | CN1962681A A plurality of antineoplastic sapogenin and its injection preparation method |
| 05/16/2007 | CN1961957A Anti-aging colon absorption preparation |
| 05/16/2007 | CN1961956A Aseptic powder injection used for breasts of cow with mastitis and preparation method thereof |
| 05/16/2007 | CN1961955A Chinese medicinal formulation for treating hyperplasia of prostate |
| 05/16/2007 | CN1961954A Externally applied transdermal Chinese medicinal formulation for treating skin cancer |
| 05/16/2007 | CN1961953A Tablet with chain fern and black snake for treating bone disease |
| 05/16/2007 | CN1961951A Chinese medicinal formulation for treating hydrocephalus |
| 05/16/2007 | CN1961950A Method for preparing Chinese medicinal soft capsule for stopping cough and resolving phlegm and formulation prepared thereby |
| 05/16/2007 | CN1961949A Chinese medicine for treating coronary heart disease |
| 05/16/2007 | CN1961947A Chinese medicine capable of treating depression and beautifying face and preparation method thereof |
| 05/16/2007 | CN1961946A Medicament for treating tumor and ulcer and preparation method thereof |
| 05/16/2007 | CN1961945A Herbal liquor impregnated agent cover |
| 05/16/2007 | CN1961942A Chinese medicinal formulation for caring and enlarging breast |
| 05/16/2007 | CN1961941A Chinese medicinal formulation for caring and enlarging breast |
| 05/16/2007 | CN1961940A Pure Chinese medicinal granule for treating infant asthma and preparation method thereof |
| 05/16/2007 | CN1961938A Pharmaceutical composition for treating angina pectoris and preparation method thereof |
| 05/16/2007 | CN1961937A Ointment for moving blood, resolving stasis, reducing swelling and easing pain and preparation process thereof |
| 05/16/2007 | CN1961934A Method for preparing Chinese medicinal wine for treating humerus lateral epicondylitis |
| 05/16/2007 | CN1961933A Hyperosteogeny-resisting formulation for treating orthopaedics disease, preparation method and quality control method thereof |
| 05/16/2007 | CN1961932A Capsule containing oldenlandia and Urena lobata |
| 05/16/2007 | CN1961931A 'Hua Hong' effervescence tablet for treating female chronic pelvic inflammation |
| 05/16/2007 | CN1961929A 'Yi Kang Bu Yuan' formulation for benefiting qi, moving blood, invigorating spleen and tonifying kidney, its preparation method and quality control method |
| 05/16/2007 | CN1961928A Blood circulation-activating stasis-removing medicament for treating blood stasis syndrome and preparation process thereof |
| 05/16/2007 | CN1961927A Pharmaceutical composition for treating acute and chronic inflammation of trachea-bronchia and preparation process thereof |
| 05/16/2007 | CN1961924A Treatment of cardiac insufficiency and cardiac failure by using 'Shen Gui' capsule |
| 05/16/2007 | CN1961922A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 05/16/2007 | CN1961921A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 05/16/2007 | CN1961920A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 05/16/2007 | CN1961919A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |
| 05/16/2007 | CN1961918A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, preparation method and application thereof |